Drugs profiteering hits patients

Nina Lakhani
Sunday 22 May 2011 00:00 BST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Thousands of patients regularly experience delays in obtaining essential medicines because profiteering traders are selling drugs intended for the NHS to higher-paying European countries – more than 18 months after the Government promised to tackle the problem.

MPs, pharmacists and patient groups say the Government must strengthen legislation to outlaw the export of scarce drugs because self-regulation has failed. More than 40 per cent of pharmacists are aware of "serious patient incidents" because of the shortages; two-thirds know patients who have been forced to miss doses, according to the National Pharmacy Association.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in